Sagent Pharmaceuticals, INC
UEI PR1HCLM3FMW7 CAGE 4RP13 Active Schaumburg, IL
Small Business · Data through September 28, 2026
Obligations by fiscal year
| Fiscal year | Obligations |
|---|---|
| FY2026 | $427K |
| FY2025 | $16.7M |
| FY2024 | $220K |
| FY2023 | $190K |
| FY2022 | $48.3M |
| FY2021 | $670K |
Agencies, NAICS, and PSC codes
| Agency | Obligations | Share |
|---|---|---|
| Department of Health and Human Services | $64.4M | 96.7% |
| Department of Defense | $1.9M | 2.9% |
| Department of Veterans Affairs | $276K | 0.4% |
| NAICS code | Obligations | Share |
|---|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | $64.7M | 97.1% |
| 325411 — Medicinal and Botanical Manufacturing | $1.9M | 2.9% |
| PSC code | Obligations | Share |
|---|---|---|
| 6505 — Drugs and Biologicals | $66.4M | 99.7% |
| 6515 — Medical and Surgical Instruments, Equipment, and Supplies | $203K | 0.3% |
Contract type and set-aside mix
| Contract pricing type | Obligations | Share |
|---|---|---|
| Firm Fixed Price | $66.6M | 100% |
| Set-aside type | Obligations | Share |
|---|---|---|
| Not Specified | $66.3M | 99.6% |
| No Set Aside Used. | $276K | 0.4% |
Place of performance by state
| State | Obligations | Share |
|---|---|---|
| IL | $66.6M | 100% |
Largest contract actions on file
| Award | Agency | Period of performance | Obligation | Record |
|---|---|---|---|---|
| 75A50322F80029 · NAICS 325412 | Department of Health and Human Services | September 26, 2022 – December 29, 2023 | $47.8M | View on USAspending |
| 75A50325F80037 · NAICS 325412 | Department of Health and Human Services | September 30, 2025 – September 29, 2026 | $16.6M | View on USAspending |
| 36C77026P0086 · NAICS 325412 | Department of Veterans Affairs | August 14, 2026 – August 28, 2026 | $276K | View on USAspending |
| SPE2D026F0104 · NAICS 325411 | Department of Defense | February 25, 2026 – April 5, 2027 | $149K | View on USAspending |
| SPE2D322F418C · NAICS 325411 | Department of Defense | August 17, 2022 – August 22, 2022 | $146K | View on USAspending |
| SPE2D024F0104 · NAICS 325411 | Department of Defense | February 29, 2024 – April 3, 2025 | $122K | View on USAspending |
| SPE2D023F0274 · NAICS 325411 | Department of Defense | March 1, 2023 – April 3, 2024 | $118K | View on USAspending |
| SPE2D321F114T · NAICS 325411 | Department of Defense | June 10, 2021 – June 15, 2021 | $88K | View on USAspending |
| SPE2D022F0106 · NAICS 325411 | Department of Defense | March 1, 2022 – April 3, 2023 | $85K | View on USAspending |
| SPE2D322F417W · NAICS 325411 | Department of Defense | August 17, 2022 – August 22, 2022 | $65K | View on USAspending |
Parent company
Nichi-Iko Pharmaceutical Co.,ltd. (UEI YDRLCQE4AJE7)
Similar contractors
- Advanced Accelerator Applications Usa INC — $74.1M, New York, NY
- Golden State Medical Supply, INC. — $56.5M, Camarillo, CA
- Sofie CO. — $54.0M, Dulles, VA
- Novartis Pharmaceuticals CORPORATION — $46.9M, East Hanover, NJ
- Ase Direct, INC. — $43.9M, Brentwood, TN
- Pharmacy Buying Association, INC. — $41.3M, Kansas City, MO
- Baxter Healthcare CORPORATION — $101.6M, Deerfield, IL
- Rls (usa) INC. — $27.7M, Lake Mary, FL
What the numbers show
97% of this contractor's obligations on file ($64.4M of $66.6M) came from a single agency, Department of Health and Human Services.
No transaction in this record used a small-business set-aside; all obligations were awarded with no set-aside or an unspecified type.
Obligations decreased from $16.7M in FY2025 to $427K in FY2026, the last closed fiscal year.
Source: USAspending.gov, U.S. Department of the Treasury. Contract transactions FY2021–FY2026, downloaded 2026-10-21. Figures are net obligations and can include de-obligations. Department of Defense data is published with a 90-day delay. View this contractor's largest contract on USAspending.gov.
To request removal of this profile, use the contact form and select "Removal request." Requests are processed within 30 days.